Dosing accuracy of two insulin pre-filled pens

ABSTRACT

Objective: This study was designed to determine the dose accuracy of two commonly available insulin pre-filled pens for use in diabetes – FlexPen^{*, †} (Novo Nordisk A/S, Bagsværd, Denmark) (FP) and SoloStar^† (Sanofi-Aventis, Paris, France) (SS).

Research design and methods: Dosing accuracy was tested at 5 U, 10 U and 30 U doses – three previously unused pens of both pre-filled pens were used for each dose. At the 5 U dose each pen was tested 42 times, at the 10 U dose each pen was tested 25 times and at the 30 U dose each pen was tested 9 times. The pre-filled pens were used strictly according to manufacturers’ instructions and measurements were made on a sensitive balance and corrected for the specific density of the insulin formulations used. Specified limits were based on ISO standards (±1 U for the 5 U and 10 U doses and ±1.5 U for the 30 U dose).

Results: FP was more accurate for injecting 5 U, 10 U and 30 U doses (absolute mean 4.95 ± 0.19 U, 9.61 ± 0.27 U and 29.70 ± 0.34 U, respectively) than SS (absolute mean 4.86 ± 0.39 U, 9.27 ± 0.52 U and 28.73 ± 0.47 U, respectively). No doses were outside specified limits for 5 U and 30 U with FP and 1.3% of doses were outside these limits at the 10 U dose. For SS; 1.6%, 29.3% and 33.3% of doses were below the pre-specified threshold for the 5 U, 10 U and 30 U doses, respectively.

Conclusions: This non-blinded comparison indicates that FP is a more accurate insulin pre-filled pen than SS at three different insulin doses. In this single-user study, FP delivered consistent and accurate doses of insulin but SS had a high frequency of under dosing. No assessment was made of user variability in this study.

Key words: :

• Dose accuracy
• FlexPen
• Insulin pen
• SoloStar